Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Overview of attention for article published in Frontiers in Neurology, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

news: 1 news outlet

facebook: 1 Facebook page

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 23 Mendeley

Summary News Facebook Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion

Article in Neurological Sciences (July 2024)

How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?

Article in Muscle & Nerve (February 2024)

Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study

Article in Orphanet Journal of Rare Diseases (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.